Global Neuroendovascular Coil Sales Market Report 2021

Endovascular coiling is a procedure performed to block blood flow into an aneurysm (a weakened area in the wall of an artery). Endovascular coiling is a more recent treatment for brain aneurysms; it has been used in patients since 1991.

A Neuroendovascular Coil is used to treat an unruptured and ruptured brain aneurysm (a weakened area in the artery wall).
Neuroendovascular coil industry concentration is very high, according to our research, the top four companies occupied above 90% market share, and the major producers include Stryker, Codman (DePuy), MicroVention, and Covidien (Medtronic). MicroVention acquired by Terumo in 2006; also Medtronic acquired Covidien in 2014.

Market Analysis and Insights: Global Neuroendovascular Coil Market
The global Neuroendovascular Coil market was valued at US$ 967.3 in 2020 and will reach US$ 1224 million by the end of 2027, growing at a CAGR of 4.0% during 2022-2027.

Global Neuroendovascular Coil Scope and Market Size
The global Neuroendovascular Coil market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuroendovascular Coil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Bare Metal Coil
Hydrogel Coated Coils

Segment by Application
Aneurysm-Embolization
Malformation-Embolization
Ischemic stroke-Revascularization
Stenosis-Revascularization

The Neuroendovascular Coil market is analysed and market size information is provided by regions (countries). Segment by Application, the Neuroendovascular Coil market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Stryker
Codman (DePuy)
MicroVention
Medtronic
Penumbra

Frequently Asked Questions